Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasodilatory Effects of Light on Peripheral Artery Disease
NCT03203239Recruiting
- Sponsor
- University of Alabama at Birmingham
- Start
- Jan 2018
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Open-label, single-arm trial in peripheral artery disease (PAD), sponsored by University of Alabama at Birmingham. Primary endpoint: Changes in blood flow. Started Jan 2018; status: recruiting.
02
Conditions
peripheral artery disease (PAD)
Beyond the preview
Go deeper on NCT03203239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03203239.